SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-08-037883
Filing Date
2008-06-05
Accepted
2008-06-04 20:30:48
Documents
7
Period of Report
2008-05-31
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a08-15948_18k.htm 8-K 42353
2 EX-99.1 a08-15948_1ex99d1.htm EX-99.1 16541
3 EX-99.2 a08-15948_1ex99d2.htm EX-99.2 19877
4 EX-99.3 a08-15948_1ex99d3.htm EX-99.3 20938
5 GRAPHIC g159481mmi001.jpg GRAPHIC 2778
6 GRAPHIC g159481moi001.jpg GRAPHIC 2778
7 GRAPHIC g159481mqi001.jpg GRAPHIC 2778
  Complete submission text file 0001104659-08-037883.txt   113269
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 7000 SHORELINE COURT SUITE 270 SO. SAN FRANCISCO CA 94080 2062817001
PONIARD PHARMACEUTICALS, INC. (Filer) CIK: 0000755806 (see all company filings)

IRS No.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16614 | Film No.: 08881792
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Assistant Director 1